Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah R Kaye

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Urology|October 8, 2013
Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomyDeborah R Kaye, M Eric Hyndman, Robert L Segal, et al.
Urologic Oncology|February 23, 2016
Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomyMeera R Chappidi, Max Kates, Hiten D Patel, et al.
Journal of Geriatric Oncology|January 8, 2022
Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinomaSamuel M Miller, Lauren E Wilson, Melissa A Greiner, et al.
Urology|September 18, 2020
Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active SurveillanceKevin B Ginsburg, Jesse C Jacobs, Ji Qi, et al.
JCO Oncology Practice|June 17, 2021
Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell CarcinomaStephanie B Wheeler, Lisa P Spees, Bradford E Jackson, et al.
Urologic Oncology|February 26, 2023
Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgeryAlex Zhu, Joel E Berends, Stephanie Daignault-Newton, et al.
Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.
Journal of Geriatric Oncology|February 7, 2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinomaDeborah R Kaye, Lauren E Wilson, Melissa A Greiner, et al.
Clinical Genitourinary Cancer|May 20, 2022
Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer AgentsLisa P Spees, Michaela A Dinan, Bradford E Jackson, et al.
JCO Oncology Practice|November 22, 2022
End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer TherapyHannah E Dzimitrowicz, Lauren E Wilson, Bradford E Jackson, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Urology|October 8, 2013
Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomyDeborah R Kaye, M Eric Hyndman, Robert L Segal, et al.
Urologic Oncology|February 23, 2016
Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomyMeera R Chappidi, Max Kates, Hiten D Patel, et al.
Journal of Geriatric Oncology|January 8, 2022
Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinomaSamuel M Miller, Lauren E Wilson, Melissa A Greiner, et al.
Urology|September 18, 2020
Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active SurveillanceKevin B Ginsburg, Jesse C Jacobs, Ji Qi, et al.
JCO Oncology Practice|June 17, 2021
Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell CarcinomaStephanie B Wheeler, Lisa P Spees, Bradford E Jackson, et al.
Urologic Oncology|February 26, 2023
Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgeryAlex Zhu, Joel E Berends, Stephanie Daignault-Newton, et al.
Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.
Journal of Geriatric Oncology|February 7, 2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinomaDeborah R Kaye, Lauren E Wilson, Melissa A Greiner, et al.
Clinical Genitourinary Cancer|May 20, 2022
Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer AgentsLisa P Spees, Michaela A Dinan, Bradford E Jackson, et al.
JCO Oncology Practice|November 22, 2022
End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer TherapyHannah E Dzimitrowicz, Lauren E Wilson, Bradford E Jackson, et al.
Pageof 6